1/12/2025Mabwell Bioscience Seeks Hong Kong Listing for Expansion

1/12/2025Lonza Capsules Expands Capsule Manufacturing Capacity in India and Chi...

1/12/2025Moderna Navigates Cautious Expansion Into China Amid Geopolitical Tens...

1/12/2025Harbour BioMed Announces License Deal with Windward Bio for HBM9378/SK...

1/12/2025Vertex and Zai Lab Announce Strategic Deal for Povetacicept in Greater...

1/12/2025Climb and Mabworks Strike Exclusive Antibody License Deal

1/12/2025HealZen and SIMM Announce Global Deal with J&J to Advance BTK Degrader

1/12/2025Keymed Biosciences and Timberlyne Therapeutics Forge Exclusive Licensi...

1/12/2025New Biotech Startups with Strong China Ties and Investor Backing Launc...

1/12/2025CMS Licensed Dimentia Drug ZUNVEYL from Alpha Cognition

1/12/2025Imunopharm Secures Series E Financing to Support IM19 Commercializatio...

1/11/2025Suzhou Hemacell Biotech Secures Multi-Million CNY Investment to Advanc...

1/11/2025Avenzo and DualityBio Announce Exclusive Global Deal for EGFR/HER3 AD...

1/11/2025BrainAurora Debuts on Hong Kong Stock Exchange as First Neurotech IPO ...

1/7/2025Cure Genetics Secures Series B Financing to Drive CGT Innovations

1/7/2025Junshi Secures NMPA Approval for Toripalimab in 2nd-Line Melanoma Trea...

1/7/2025Gene Vector Secures Strategic Financing

1/7/2025Insilico Medicine Secures Over $100M in Equity Financing to Advance AI...

1/6/2025Solasia Pharma Partners with GenSci to Boost Sales of Episil in China

1/6/2025I-Mab Reprioritizes Pipeline and Halts CD73 Development

1/6/2025WuXi Bio Divests Irish Vaccine Facility to Merck Amid Potential U.S. R...

1/3/2025Prime Gene Therapeutics Completes Over CNY 300M in Series B Financing

1/3/2025Eli Lilly China Launches Zepbound (tirzepatide) for Diabetes and Weigh...

1/3/2025HighLightHill Pharma Secures CNY 150M in Series Pre-C Financing

1/3/2025WuXi Biologics and Sino Biopharm Partner on mAb Discovery

1/3/2025New Horizon Health Faces Deeper Crisis as Chairman and CEO Step Down

1/3/2025Brii Biosciences Acquires BRII-179 Assets from VBI Vaccines

1/2/2025Hutchmed Announces $608M Non-core Chinese Unit Stake Sale

1/2/2025Roche and Innovent Enter Global License Deal for Novel DLL3 ADC 

12/30/2024Reforgene Secures Major Financing to Advance Gene-Editing Therapies

Page:14/24 Total number of articles:711: [First][<<] [12] [13] [14] [15] [16] [>>] [End]